Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Treating people with the diabetes drug metformin before a diagnosis of COVID-19 is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a study at the University of Alabama at Birmingham (UAB).
After controlling for other covariates, age, and gender, metformin use emerged as independent factors affecting COVID-19-related mortality. After controlling for all variables, death was significantly less likely — with an odds ratio of 0.33 — for Type 2 diabetes subjects taking metformin, compared with those who did not take metformin, said these UAB researchers.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive Diabetes Center and leader of the study, published on January 13, 2021.
The Wonder Drug strikes again! 😱
After controlling for other covariates, age, and gender, metformin use emerged as independent factors affecting COVID-19-related mortality. After controlling for all variables, death was significantly less likely — with an odds ratio of 0.33 — for Type 2 diabetes subjects taking metformin, compared with those who did not take metformin, said these UAB researchers.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive Diabetes Center and leader of the study, published on January 13, 2021.
Diabetes Drug Found Protective Against COVID-19
Metformin use found effective in preventing severe COVID-19
www.precisionvaccinations.com
The Wonder Drug strikes again! 😱